Limitations of the Drug Supply Chain Security Act for pharma-and three strategies to fix them.
Peter M.O. Wong
Advertisement
Articles by Peter M.O. Wong
Advertisement
Latest Updated Articles
Closing the Gaps in Drug Chain of CustodyPublished: April 28th 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
2
Direct-to-patient: pharma’s next power move
3
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
